What is the long-term trend for Microbot Medical's cash cash equivalents and short term investments?

Over 4 years (2021 to 2025), Microbot Medical's cash cash equivalents and short term investments has grown at a 50.1% compound annual growth rate (CAGR), from $15.49M to $78.59M.

Microbot Medical MBOT Cash Cash Equivalents And Short Term Investments

Cash Cash Equivalents And Short Term Investments at other companies

AmphenolAPH

$4.58B+174%

Travel + LeisureTNL

$456M+24.3%

Warrior Met CoalHCC

$210.55M-54.5%

Main Street CapitalMAIN

$20.79M-81.0%

Cabot CorporationCBT

$252M+18.3%

HES

Hess MidstreamHESM

$4.6M-24.6%

Other financials

Income statement

See full

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

See full

Operating cash flow-$5.1M-75.8%

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

See full

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

See full

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

See full

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsAndShortTermInvestments.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's cash cash equivalents and short term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Microbot Medical's cash cash equivalents and short term investments?: Microbot Medical (MBOT) reported cash cash equivalents and short term investments of $72.5M in Q1 2026.
How has Microbot Medical's cash cash equivalents and short term investments changed year-over-year?: Microbot Medical's cash cash equivalents and short term investments increased by 138.6% year-over-year, from $30.39M to $72.5M.
What is the long-term trend for Microbot Medical's cash cash equivalents and short term investments?: Over 4 years (2021 to 2025), Microbot Medical's cash cash equivalents and short term investments has grown at a 50.1% compound annual growth rate (CAGR), from $15.49M to $78.59M.